Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

A sweeping review of clinical trials uncovered 64 OTC products studied for depression, with only a handful showing consistent promise. Many people are familiar with remedies like St John’s Wort or ...

In a 2023 study published in the British Journal of Sports Medicine, researchers analyzed data from 128,119 participants ...

New research published in Psychopharmacology has found that damaging a specific brain region called the nucleus reuniens ...

A massive global survey has revealed that people with eating disorders often turn to cannabis and psychedelics like magic mushrooms and LSD to ease their symptoms, rating them more effective than ...

Up to 85,000 new mothers in England may have been impacted by postnatal depression last year, according to new analysis. The illness can be “truly devastating” when left untreated, potentially leading ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

Her doctor prescribed an antidepressant, even though the then 36-year-old insisted she wasn’t depressed. She even went to ...